Investigational drug shows promise in ovarian cancer
Wednesday, September 17, 2008 - 07:14
in Health & Medicine
An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.